German group’s drugs chief warns EU and UK are dissuading investment as company prioritises US and China
Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe
Recent Posts
- Israeli invasion brings fresh violence to hills of southern Lebanon
- UK homes to be offered payments to cut electricity use all year round
- Vistry shares plunge more than 30% after UK group issues profit warning
- Ofwat charges UK water companies £158mn for poor performance
- Top Fed official says US economy ‘well positioned’ for soft landing